Page last updated: 2024-08-25

tyloxapol and Familial Hypobetalipoproteinemia

tyloxapol has been researched along with Familial Hypobetalipoproteinemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Averna, MR; Chen, Z; Fitzgerald, RL; Schonfeld, G1

Other Studies

1 other study(ies) available for tyloxapol and Familial Hypobetalipoproteinemia

ArticleYear
A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
    The Journal of biological chemistry, 2000, Oct-20, Volume: 275, Issue:42

    Topics: Animals; Apolipoprotein B-100; Apolipoproteins B; Base Sequence; Cells, Cultured; Cholesterol; Fatty Liver; Hepatocytes; Humans; Hypobetalipoproteinemias; Intestine, Small; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Transgenic; Phospholipids; Polyethylene Glycols; Polymerase Chain Reaction; Sequence Alignment; Sequence Homology, Nucleic Acid; Surface-Active Agents; Triglycerides

2000